Boehringer-Ingelheim

Boehringer Ingelheim, founded in 1885 by Albert Boehringer in Ingelheim, Germany, began with just 28 people employed to manufacture tartaric acid salts. Now, more than 125 years later, the company operates globally with 146 affiliates and more than 47,000 employees. Our focus is primarily in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.

Share
900 Ridgebury Road Ridgefield, CT 06877
Tel: 1-800-556-8317

PharmTech News Articles

FDA issued a warning letter to Cixi Zhixin Bird Clean-Care Product Co., Ltd for violations of cGMP for finished pharmaceuticals.

The company announced an investment in a new facility in Dundalk, County Louth, Ireland.

Pharmco Laboratories received an FDA warning letter for significant violations of CGMP for finished drugs and APIs at its Florida, US facility as well as misbranding of over-the-counter (OTC) acne and sunscreen drug products.

Novo Nordisk entered a research collaboration with the University of Oxford focused on Type 2 diabetes.